- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04351568
Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;
June 1, 2020 updated by: Noha Esmael Ebrahem, Assiut University
Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services; During the Period of 19 Covid Pandemics
integrating social media into medicine has obvious potential to improve patient care and trust in the profession, in part by meeting patients "where they are," i.e., online, at the same time carries a greater risk in terms of legal, ethical, and professional aspects.
Therefore, physicians and medical students using social media should pay attention to the ethical sensitivity in their relationships with patients .it
also raises a number of ethical issues including protecting patient and physician privacy; setting appropriate online boundaries; and delineating personal and professional identities among others during covid 19 pandemics
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
874
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt
- Recruiting
- Assiut
-
Contact:
- Noha E. Ebrahem, MD
- Phone Number: + 0201062664072
- Email: nohaesmaiel@gmail.com
-
Contact:
- Doaa M. El Shehaby, MD
- Phone Number: + 0201007361718
- Email: drdoaamoh@yahoo.com
-
Principal Investigator:
- Doaa M. El Shehaby, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
medical and non medical personel
Description
Inclusion Criteria:
- adult aged 18 years to 60 years
- medical personel graduated from egyptian faculty of medicine.
- non medical personel live in egypt
Exclusion Criteria:
- personel less than 18 years old .
- medical personel not graduated from egyptian faculty of medicine.
- non medical personel live outside egypt
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
medical personel
|
questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality
|
non medical personel
|
questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
to evaluate the effect of social media usage in medical practice during covid 19 epidemic
Time Frame: 3 months
|
to evaluate the effect of social media usage in medical practice during covid 19 epidemic
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2020
Primary Completion (Anticipated)
July 1, 2020
Study Completion (Anticipated)
August 1, 2020
Study Registration Dates
First Submitted
April 14, 2020
First Submitted That Met QC Criteria
April 15, 2020
First Posted (Actual)
April 17, 2020
Study Record Updates
Last Update Posted (Actual)
June 2, 2020
Last Update Submitted That Met QC Criteria
June 1, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 2020A20
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.